Bo Zhang

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Yunhang Guo, Ye Liu, Nan Hu et al. · Journal of Medicinal Chemistry · 2019 · 349 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages

Zhangting Yao, Jieqiong Zhang, Bo Zhang et al. · Pharmacological Research · 2018 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17

BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy

Rui Li, Hao Tang, Jeremy C. Burns et al. · Acta Neuropathologica · 2022 · 72 citations · Full text

Life Sciences, Immunology, Pharmacology +17

BTK Leu528Trp - a Potential Secondary Resistance Mechanism Specific for Patients with Chronic Lymphocytic Leukemia Treated with the Next Generation BTK Inhibitor Zanubrutinib

Sasanka M. Handunnetti, Chloe Pek Sang Tang, Tamia Nguyen et al. · Blood · 2019 · 67 citations

Medicine, Oncology, Pharmacology +9

Peripheral infusion of human umbilical cord mesenchymal stem cells rescues acute liver failure lethality in monkeys

Gang Guo, Xiang Zhuang, Qing Xu et al. · Stem Cell Research & Therapy · 2019 · 63 citations · Full text

Medicine, Cell Biology, Immunology +17